*Corresponding Author:
M. A. Azam
Department of Pharmaceutical Chemistry, J. S. S. College of Pharmacy, Ootacamund-643 001, India
E-mail: [email protected]
Date of Submission 2 November 2007
Date of Decision 25 March 2008
Date of Acceptance 15 October 2008
Indian J Pharm Sci, 2008, 70 (5): 672-677  


A number of substituted-a,β -unsaturated carbonyl compounds (1a-i) were prepared by Claisen-Schmidt condensation of substituted acetophenone with selected araldehydes, which on cycloaddition with thiourea furnished 4,6-disubstituted pyrimidine-2-thiols (2a-i). Reaction of (2a-i) with ethyl chloroacetate followed by condensation with hydrazine hydrate yielded 2-[(4,6-disubstituted pyrimidine-2-yl) thio] acetohydrazides (4a-c). Condensation of compounds (4a-c) with phenyl isothiocyanate gave 2-{[(4,6-disubstituted pyrimidine-2-yl) thio] acetyl}-N-phenylhydrazinecarbothioamides (5a-c) which on treatment with concentrated sulphuric acid afforded titled compounds 5-{(4,6-disubstituted pyrimidine-2-yl) thio] methyl}-N-phenyl-1,3,4-thiadiazole-2-amines (6a-c). These compounds have been characterized on the basis of elemental analysis, IR, 1 H NMR and MS. Compounds have been evaluated for their anticancer and antioxidant activities. Compounds 2b, 2c and 6b exhibited significant antitumor activity against human breast cancer MCF 7 cell line. However, moderate antioxidant activity was observed with compounds 2c, 2d, 2g and 6b.


Thiadiazoles, pyrimidines, chalcones, thiourea and anticancer activity

In recent years pyrimidine derivatives have received significant attention owing to their diverse range of biological properties particularly being antifungal [1], antitubercular [2], antibacterial [3,4], antiviral [5-8], anticancer [9] and antioxidant [10]. 2,5-Disubstituted-1,3,4-thiadiazoles represent one of the most active classes of compounds possessing wide spectrum of biological activities. 2,5- Disubstituted-1,3,4-thiadiazole derivatives exhibit in vitro antimycobacterial [11], antibacterial [12], anticancer [13,14] and antioxidant [15] properties. Considering the above facts, the goal of the present study was to combine disubstituted pyrimidines with 1,3,4-thiadiazole residues in order to develop hybrid molecules with potential of enhanced activity and to test their antioxidant and antitumor activities.

Melting points were taken in open capillary tubes and are uncorrected. The IR spectra (KBr, cm-1) were recorded on a Shimadzu FTIR 800 series spectrophotometer and 1H NMR spectra (CDCl3) on Varian EM 390 MHz spectrometer using TMS as internal standard. Mass spectra were recorded on Shimadzu 2010A LC-MS system. The reactions were monitored by thin layer chromatography using silica gel plates and detected by UV chamber and iodine as visualizing agent. The purity of the compounds was checked on silica gel precoated plates. All the solvents used were purified according to the standard methods [16]. Phenyl isothiocyanate was prepared according to the standard method [17].

For the preparation of 4, 6-disubstituted pyrimidine- 2-thiols (2a-i) a mixture of appropriate chalcones (1a-i, Scheme 1) (0.01 mol) and thiourea (0.01 mol) in ethanol (50 ml) and sodium hydroxide (0.01 mol) dissolved in minimum quantity of water was refluxed on a water bath for 12 h and poured into 250 ml of cold water. The solid that separated in each case was filtered, washed with water and recrystallized from ethyl acetate (Table 1); 2a: IR (KBr, cm-1): 3095 (aromatic C-H str.), 2830 (S-H str.), 1640 (C=N), 1590, 1610 (aromatic C=C str.), 1520 (C-N str.); MS: m/z 264 (M+); Anal. Calcd. for C16H12N2S: C, 72.72; H, 4.54; N, 10.60. Found: C, 72.75; H, 4.58; N, 10.56%; 2b: IR (KBr, cm-1): 3120 (aromatic C-H str.), 2840 (S-H str.), 1651 (C=N), 1582, 1606 (aromatic C=C str.), 1516 (C-N str.), 1265 (C-O-C); 1H NMR (CDCl3): δ 9.72 (s, 1H, SH), 6.81-8.32 (m, 11H, aromatic and heterocyclic), 3.75 (s, 3H, OCH3); MS: m/z 294 (M+); Anal. Calcd. for C17H14N2OS: C, 69.38; H, 4.76; N, 9.52. Found: C, 69.37; H, 4.81; N, 9.58%; 2c: IR (KBr, cm-1): 3330 (OH), 3088 (aromatic C-H str.), 2842 (S-H str.), 1649 (C=N), 1608 (aromatic C=C str.), 1518 (C-N str.); MS: m/z 280 (M+); Anal. Calcd. for C16H12N2 OS : C, 68.57; H, 4.28; N, 10.00. Found: C, 68.61; H, 4.31; N, 9.97%; 2d: IR (KBr, cm-1): 3360 (OH), 3082 (aromatic C-H str.), 2835 (S-H str.), 1635 (C=N), 1580, 1608 (aromatic C=C str.), 1524 (C-N str.), 1280 (C-O-C); MS: m/z 310 (M+); Anal. Calcd. for C17H14N2SO2 : C, 65.80; H, 4.51; N, 9.03. Found: C, 65.68; H, 4.54; N, 9.10%; 2e: IR (KBr, cm-1): 3082 (aromatic C-H str.), 2820 (S-H str.), 1635 (C=N), 1580, 1608 (aromatic C=C str.), 1524 (C-N str.), 1345 (NO2), 1275 (C-O-C); MS: m/z 339 (M+); Anal. Calcd. for C17H13N3O3S : C, 60.17; H, 3.83; N, 12.38. Found: C, 60.12; H, 3.85; N, 12.33%; 2f: IR (KBr, cm-1): 3328 (OH), 3086 (aromatic C-H str.), 2840 (S-H str.), 1644 (C=N), 1580, 1605 (aromatic C=C str.), 1524 (C-N str.); MS: m/z 280 (M+); Anal. Calcd. for C16H12N2 OS : C, 68.57; H, 4.28; N, 10.00. Found: C, 68.63; H, 4.34; N, 9.93%; 2g: IR (KBr, cm-1): 3330 (OH), 3060 (aromatic C-H str.), 3010 (C=C, alkene), 2825 (S-H str.), 1615 (C=N), 1598 (aromatic C=C str.), 1524 (C-N str.); MS: m/z 306 (M+); Anal. Calcd. for C18H14N2OS : C, 70.58; H, 4.57; N, 9.15. Found: C, 70.60; H, 4.53; N, 9.19%; 2h: IR (KBr, cm-1): 3310 (OH), 3072 (aromatic C-H str.), 2833 (S-H str.), 1618 (C=N), 1585 (aromatic C=C str.), 1520 (C-N str.), 1105 (C-O-C); MS: m/z 270 (M+); Anal. Calcd. for C14H10N2O2S: C, 62.22; H, 3.70; N, 10.37. Found: C, 62.28; H, 3.67; N, 10.29%; 2i: IR (KBr, cm-1): 3075 (aromatic C-H str.), 2830 (S-H str.), 1610 (C=N), 1605 (aromatic C=C str.), 1522 (C-N str.), 1352 (NO2); MS: m/z 334 (M+); Anal. Calcd. for C18H12N3O2S : C, 64.67; H, 3.59; N, 12.57. Found: C, 64.60; H, 3.62; N, 12.61%.


Scheme 1: Synthesis of {[(4,6-disubstitutedpyrimidine-2-yl)thio] methyl}-N-phenyl-1,3,4-thiadiazol-2-amine R= -C6H5, 2-OH.C6H4 and 4-NO2.C6H4, R’= -C6H5, 4-OCH3.C6H4, 2-OH. C6H4, -CH=CH.C6H5 and 3-furyl

Compd. R R' Mol. Formula M.P. 0C %Yielda
1a C6H5 C6H5 C15H12O 57 80
1b C6H5 4-OCH3.C6H4 C16H14O2 72 85
1c C6H5 2-OH.C6H4 C15H12O2 66 81
1d 2-OH.C6H4 4-OCH3.C6H4 C6H14O3 75 78
1e 4-NO2.C6H4 4-OCH3.C6H4 C16H13O4N 77 65
1f 2-OH.C6H4 C6H5 C15H12O2 60 85
1g 2-OH.C6H4 C6H5CH=CH- C17H14O2 69 55
1H 2-OH.C6H4 3-furyl C13H10O3 82 67
1i 4-NO2.C6H4 C6H5.CH=CH- C17H13O3N 78 60
2a C6H5 C6H5 C16H12N2S 165 81
2b C6H5 4-OCH3.C6H4 C17H14N2OS 80 75
2c C6H5 2-OH.C6H5 C16H12N2OS 130 56
2d 2-OH.C6H4 4-OCH3.C6H4 C17H14N2O2S 120 84
2e 4-NO2.C6H4 4-OCH3.C6H4 C17H13N3O3S 140 96
2f 4-OH.C6H4 C6H5 C16H12N2OS 175 89
2g 2-OH.C6H4 C6H5.CH=CH- C18H14N2OS 265 77
2h 2-OH.C6H4 3-Furyl C14H10N2O2S 101 82
2i 4-NO2.C6H4 C6H5.CH=CH- C18H12N3O2S 270 63
3a C6H5 C6H5 C20H18N2O2S 118 86
3b C6H5 4-OCH3.C6H4 C21H20N2O3S 198 65
3c C6H5 2-OH.C6H4 C20H18N2O3S 212 57
4a C6H5 C6H5 C18H16N4OS 202 65
4b C6H5 4-OCH3.C6H4 C19H18N4O2S 199 55
4c C6H5 2-OH.C6H4 C18H16N4O2S 215 61
5a C6H5 C6H5 C25H21N5OS2 186 62
5b C6H5 4-OCH3.C6H4 C26H23N5O2S2 189 53
5c C6H5 2-OH.C6H4 C25H21N5O2S2 175 64
6a C6H5 C6H5 C25H19N5S2 198 56
6b C6H5 4-OCH3.C6H4 C26H21N5OS2 210 51
6c C6H5 2-OH.C6H4 C25H19N5OS2 235 58

Table 1: Characterization Data of Synthesized Compoundsd

Preparation of ethyl [(4,6-disubstituted pyrimidine- 2-yl) thio] acetates (3a-c) was achieved by mixing equimolar quantities of 4,6-disubstituted pyrimidine- 2-thiols (2a-c) (0.017 mol), ethyl chloroacetate (2.017 g, 0.017 mol) and anhydrous potassium carbonate (1.10 g, 0.01 mol) in dry acetone (15 ml) and refluxing on a water bath for about 13 h. The mixture was then diluted with benzene and washed with water. The organic layer was dried (Na2SO4) and the solvent was removed under reduced pressure. The resulting solid in each case was recrystallized from benzene:petroleum ether (1:1) (Table 1); 3a: IR (KBr, cm-1): 3065 (aromatic C-H str.), 2910, 2886 (aliphatic C-H str.), 1745 (>C=O of ester), 712 (C-S-C); MS m/z: 350 (M+); Anal. Calcd. for C20H18N2O2S: C, 68.57; H, 5.14; N, 8.00. Found: C, 68.61; H, 5.18; N, 7.95%; 3b: IR (KBr, cm-1): 3061 (aromatic C-H str.), 2912, 2875 (aliphatic C-H str.), 1736 (>C=O of ester), 1240 (C-O-C), 710 (C-S-C); 1H NMR (CDCl3): δ 6.82-8.10 (m, 10H, aromatic and heterocyclic), 4.32 (q, 2H, COOCH2CH3), 4.12 (s, 2H, S-CH2-CO), 3.72 (s, 3H, OCH3), 1.05 (t, 3H, -COOCH2CH3); MS m/z: 380 (M+); Anal. Calcd. for C21H20N2O3S: C, 66.31; H, 5.26; N, 7.36. Found: C, 66.25; H, 5.32; N, 7.29%; 3c: IR (KBr, cm-1): 3320 (OH), 3070 (aromatic C-H str.), 2930, 2885 (aliphatic C-H str.), 1742 (>C=O of ester), 715 (C-S-C); MS m/z: 366 (M+); Anal. Calcd. for C20H18N2O3S: C, 65.57; H, 4.91; N, 7.65. Found: C, 65.63; H, 5.14; N, 7.58%.

For preparation of 2-[(4,6-disubstituted pyrimidine- 2-yl) thio] acetohydrazides (4a-c), a solution of the appropriate esters (3a-c) (0.01 mol), hydrazine hydrate (3.5 ml) and ethanol (25 ml) was refluxed on a water bath for about 10 h. The solvent was then removed under reduced pressure and the residue obtained in each case was recrystallized from methanol (Table 1); 4a: IR (KBr, cm-1): 3420, 3375 (NH-NH2) 1660 (>C=O, amido), 1622 (C=N str.), 1605 (aromatic C=C), 715 (C-S-C); MS m/z: 336 (M+); Anal. Calcd. for C18H16N4OS: C, 64.28; H, 4.76; N, 16.66. Found: C, 64.33; H, 4.69; N, 16.71%; 4b: IR (KBr, cm-1): 3438, 3380, 3310 (NH-NH2) 1653 (>C=O, amido), 1642 (C=N str.), 1598 (aromatic C=C), 1250 (C-O-C), 712 (C-S-C); 1H NMR (CDCl3): δ 9.51 (s, 1H, CONH), 6.82-7.91 (m, 10H, aromatic and heterocyclic), 6.49 (bs, 2H, NH2), 4.20 (s, 2H, S-CH2-CO), 3.71 (s, 3H, OCH3); MS m/z: 366 (M+); Anal. Calcd. for C19H18N4O2S: C, 62.29; H, 4.92; N, 15.30. Found: C, 62.31; H, 4.87; N, 15.29%; 4c: IR (KBr, cm-1): 3380 (OH), 3345, 3320 (NH-NH2), 1668 (>C=O, amido), 1622 (C=N str.), 1598 (aromatic C=C), 711 (C-S-C); MS m/z: 352 (M+); Anal. Calcd. for C18H16N4O2S: C, 61.36; H, 4.54; N, 15.90. Found: C, 61.41; H, 4.59; N, 15.83%.

For preparation of 2-[(4, 6-disubstituted pyrimidine- 2-yl) thio] acetyl-N-phenylhydrazine carbothiamide (5a-c), a mixture of the acid hydrazides (4a-c) (0.01 mol) and phenylisothiocyanate (0.0015 mol) in ethanol (10 ml) was refluxed on a water bath for about 8 h. The solution was allowed to reach ambient temperature and the resulting solid in each case was collected and recrystallized from methanol (Table 1); 5a: IR (KBr, cm-1): 3225, 3215, 3180 (N-H), 3035, (aromatic C-H str.), 1670 (>C=O), 1625 (C=N), 1605 (aromatic C=C str.), 1450 (>C=S), 718 (C-S-C); MS m/z: 471 (M+); Anal. Calcd. for C25H21N5OS2: C, 63.69; H, 4.45; N, 14.86. Found: C, 63.72; H, 4.37; N, 14.79%; 5b: IR (KBr, cm-1): 3120-3218 (N-H), 3024 (aromatic C-H str.), 1681 (>C=O), 1667 (C=N), 1605 (aromatic C=C str.), 1453 (>C=S), 1255 (C-O-C), 710 (C-S-C); 1H NMR (CDCl3): δ 8.20-10.12 (m, 3H, NH.NH.CS.NH), 7.21-7.92 (m, 15H, aromatic and heterocyclic), 4.21(s, 2H, S-CH2- CO), 3.48 (s, 3H, OCH3); MS m/z: 501 (M+); Anal. Calcd. for C26H23N5O2S2: C, 62.27; H, 4.59; N, 13.97. Found: C, 61.98; H, 4.48; N, 13.89%; 5c: IR (KBr, cm-1): 3340 (OH), 3218, 3205, 3185 (N-H), 3045, (aromatic C-H str.), 1695 (>C=O), 1625 (C=N), 1598 (aromatic C=C str.), 1448 (>C=S), 714 (C-S-C); MS m/z: 487 (M+); Anal. Calcd. for C25H21N5O2S2: C, 61.60; H, 4.31; N, 14.37. Found: C, 61.67; H, 4.39; N, 14.31%.

For preparation of 5-{[(4,6-disubstituted pyrimidine- 2-yl) thio] methyl}-N-phenyl-1,3,4-thiadiazol-2- amine (6a-c), a mixture of the appropriate thiosemicarbazides (5a-c) (0.001 mol) in cold concentrated sulphuric acid (3 ml) was stirred for 10 min the resulting solution was then allowed to reach ambient temperature and poured cautiously into ice cold water. The reaction mixture was made alkaline to pH 8 with aqueous ammonia and the precipitated product in each case was collected washed with cold water and recrystallized from ethanol (Table 1); 6a: 3395 (N-H), 3095 (aromatic C-H str.), 2955 (C-H str.), 1620 (C=N, str.), 1605 (aromatic C=C str.), 740 (C-S-C, thiadiazole), 710 (C-S-CH2); MS m/z: 453 (M+); Anal. Calcd. for C25H19N5S2: C, 66.22; H, 4.19; N, 15.45. Found: C, 66.29; H, 4.14; N, 15.39%; 6b: 3440 (N-H), 3211 (aromatic C-H str.), 2939 (C-H str.), 1665 (C=N, str.), 1599 (aromatic C=C str.), 1248 (C-O-C), 746 (C-S-C, thiadiazole), 708 (C-S-CH2); 1H NMR (CDCl3): δ 9.3 (s, 1H, NH), 7.21-8.32 (m, 15H, aromatic and heterocyclic), 3.38 (s, 3H, OCH3), 3.61 (s, 2H, -CH2-); MS m/z: 483 (M+); Anal. Calcd. for C26H21N5OS2: C, 64.59; H, 4.34; N, 14.49. Found: C, 64.61; H, 4.42; N, 14.51%; 6c: 3380 (N-H), 3345 (OH), 3070 (aromatic C-H str.), 2975 (C-H str.), 1612 (C=N, str.), 1610 (aromatic C=C str.), 726 (C-S-C, thiadiazole), 712 (C-S-C); MS m/z: 469 (M+); Anal. Calcd. for C25H19N5OS2: C, 63.96; H, 4.05; N, 14.92. Found: C, 64.11; H, 4.09; N, 14.89%.

Determination of In vitro antioxidant activity was done by DPPH (1,1-diphenyl-2-picrylhydrazyl) [18] and nitric oxide [19] free radical scavenging methods. The methods were used to screen compounds (2a-i) and (6a-c) for the antioxidant activity. Ascorbic acid and rutin were used as reference standards at a concentration level of 100 μg/ml. Results are presented in Table 2.

Compd.       Antioxidant activity       Average percent growth values** at 20  M in MCF-7 cell line  
DPPH method IC50 ( g/ml)* Nitric oxide method IC50 ( g/ml)*
2a >500 105 67.77
2b >500 160 13.33
2c 56 95 0
2d 50.5 90 79.98
2e 84 >500 34.44
2f >500 125 94.44
2g 60 200 77.50
2h 84 >500 43.55
2i >500 >500 97.4
6a 82 143 68.54
6b 92 87 12.55
6c 78 >500 58.50
  18 69 --
  (ascorbic acid) (rutin)  

Table 2: In Vitro Anticancer And Antioxidant Activities Of Compounds (2a-I) And (6a-C)

Antitumor activity of the compounds was evaluated by tryphan blue dye exclusion technique [20] against human breast cancer MCF-7 cell line at 20 μM concentration. Primary screening of the compounds was done to indicate whether a substance possessed enough activity at this concentration to inhibit cell growth by 50%. Results are presented in Table 2.

Chalcones (1a-i) required as starting material were prepared [21] by stirring equimolar solution of various substituted acetophenones and araldehydes in the presence of sodium hydroxide in ethanol at room temperature (Scheme 1). Solution in ethanol of chalcones (1a-i) and thiourea in the presence of sodium hydroxide was refluxed on a water bath to yield 4,6-disubstituted pyrimidine-2-thiols (2a-i). When thiols (2a-c) and ethyl chloroacetate was refluxed in the presence of anhydrous sodium carbonate resulted in the formation of ethyl [(4,6-disubstituted pyrimidine-2-yl) thio] acetates (3a-c). Compounds (3a-c), hydrazine hydrate in ethanol as a reaction media afforded 2-[(4,6-disubstitutedpyrimidine- 2-yl) thio] acetohydrazides (4a-c), which on condensation with phenyl isothiocyanate in ethanol gave 2-{[(4,6-disubstituted pyrimidine-2-yl) thio] acetyl}-N-phenylhydrazinecarbothioamides (5a-c). The compounds (5a-c) on treatment with concentrated sulphuric acid yielded 5-{[(4,6-disubstituted pyrimidine-2-yl) thio] methyl}-N-phenyl-1, 3, 4-thiadiazol-2-amines (6a-c). All the compounds synthesized were characterized by their elemental analysis, IR and 1H NMR spectra. The physical and chemical data are presented in Table 1. In the IR spectrum of 2b, the presence of band at 2840 cm-1 (SH) and the absence of band due to >C=O confirmed the formation of pyrimidine-2-thiol moiety. The appearance of singlet at δ 9.72 due to SH also confirmed the formation of 2b. The IR spectrum of 5b exhibited band at 1681 cm-1 (>C=O), 1667 cm-1 (>C=N) and 3120-3218 cm-1 due to N-H. The 1H NMR spectrum of 5b exhibited the aromatic and heterocyclic protons as a multiplet integrating for 15 protons from δ 7.21-7.92 and a multiplet integrating for 3 protons from δ 8.20-10.12 due to NH.NH. CS.NH. In the IR spectrum of 6b, the disappearance of bands at 1681 cm-1 (>C=O) and 1453 cm-1 (>C=S) and the appearance of band at 746 cm-1 (C-S-C) confirmed the formation of thiadiazole ring. The 1H NMR spectrum of 6b exhibited the aromatic and heterocyclic protons as a multiplet integrating for 15 protons from δ 7.21-8.32 and a singlet at δ 9.3 integrating for one proton due to NH. In the mass spectra, the molecular ion peak at 483 (M+) also confirmed the formation of titled compound 6b.

Compound 2c, 2d, 2g and 6b showed moderate DPPH free radical scavenging activity while all other compounds were found to be less active. Compounds 2c, 2d and 6b showed moderate nitric oxide free radical scavenging activity and all other compounds were found to be less active. As shown in Table 2 compounds 2b, 2c and 6b exhibited significant activity against human breast cancer MCF-7 cell line, while compounds 2e and 2h showed moderate cytotoxicity.


The authors wish to place their regards to His Holiness Jagadguru Sri Sri Sri Shivarathri Deshikendra Mahaswamigalavaru of Sri Suttur mutt, Mysore for providing facilities.